ArticleJournal of enzyme inhibition and medicinal chemistry2022

A new era for the design of TRPV1 antagonists and agonists with the use of structural information and molecular docking of capsaicin-like compounds.

Julio CaballeroPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.